Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classifica tra le azioni #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Prezzo delle azioni
$0.12164306
Ultima sincronizzazione: 2024-11-11
Capitalizzazione di mercato
$38.53M
Variazione (1 giorno)
-4.14%
Variazione (1 anno)
0.00%
Paese
AU
Scambia PharmAust Limited (PAA)

Categoria

EPS per PharmAust Limited (PAA)
EPS al June 2024 TTM: $-0.01
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di PharmAust Limited, l’EPS attuale della società (TTM) è $-0.01. Alla fine del 2023, la società aveva un EPS di $-0.01 una diminuzione rispetto a rispetto a quello del 2022, che era di $0.00.
Storico EPS per PharmAust Limited da 2001 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.01 -41.50%
2024 $-0.02 26.36%
2023 $-0.01 248.65%
2022 0.00 19.35%
2021 0.00 -3.13%
2020 0.00 -36.00%
2019 $-0.01 -60.63%
2018 $-0.01 53.01%
2017 $-0.01 -73.82%
2016 $-0.03 61.73%
2015 $-0.02 4.81%
2014 $-0.02 23.03%
2013 $-0.02 -90.70%
2012 $-0.16 -57.64%
2011 $-0.39 1,413.73%
2010 $-0.03 142.86%
2009 $-0.01 -97.72%
2008 $-0.46 -48.36%
2007 $-0.89 96.82%
2006 $-0.45 -40.46%
2005 $-0.76 -18.86%
2004 $-0.94 -11.50%
2003 $-1.06 -45.34%
2002 $-1.94 47.75%
2001 $-1.31 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -148,134.19%
US
$27.74 -237,194.02%
NL
$2.98 -25,570.09%
AU
$-7.98 68,105.13%
US
- -
CH